Suggestions
Dr. Vaclav Potesil
Founder, Director, medical AI expert
Dr. Vaclav Potesil is a prominent figure in the field of medical artificial intelligence and lung health technology. He is the Founder, Chief Business Officer, and Board Director of Optellum, a lung health startup based in Oxford, UK.1
Professional Background
Dr. Potesil holds a Doctorate (D.Phil) in Machine Learning from the University of Oxford, where he collaborated with Siemens Healthineers and Mirada Medical. He also has an M.Phil in Computational Biology from the University of Cambridge.1
Career Highlights
- Optellum: Founded the company in May 2016 and served as CEO until August 2021. Since September 2021, he has been the Chief Business Officer and Board Director.2
- Hocoma AG: Worked as Global Product Manager from April 2013 to April 2016, launching novel medical robotics devices.2
- Siemens Healthineers: Served as a Research Scientist in Medical Image Analysis from July 2007 to July 2011.2
Optellum's Mission
Under Dr. Potesil's leadership, Optellum has developed an AI-powered decision support platform that assists physicians in early diagnosis and optimal treatment of lung cancer. This software has secured FDA and CE-MDR clearance, as well as CMS Medicare reimbursement under New Technology APC.1
Expertise and Vision
Dr. Potesil is an expert in applying computer vision and AI to lung cancer therapy planning. At Optellum, he leads partnerships with major companies like Johnson & Johnson and GE Healthcare, aiming to make Optellum the "Intel Inside" of early lung cancer interception.2
International Experience
Throughout his career, Dr. Potesil has worked and studied in eleven countries and speaks seven languages, demonstrating his global perspective and adaptability in the field of medical technology.1
Highlights
We're thrilled to showcase how our AI-powered solutions, combined with advanced robotics and imaging, are transforming precision lung interventions and improving patient outcomes. Discover the future of lung cancer care at #AABIP2024 booths #7A (Optellum) and #26 (GE HealthCare) from August 22-24 in Charlotte, NC.
Learn how our FDA-approved Virtual Nodule Clinic is revolutionizing early lung cancer diagnosis and treatment, enabling more accurate biopsies saving patients' lives.
Read more here https://lnkd.in/djKaJhqS
#LungCancer #AIHealth #MedTech #PrecisionMedicine #AABIP
Excited to launch our multi-modal cancer therapy AI platform for life sciences at #ASCO24: Enabling our biopharma partners to save lives through optimized curative treatment, driving earlier lung cancer identification, recurrence prognosis, and therapy response prediction and monitoring. Our AI recurrence prognosis study - showing significant improvement over TNM staging - to be presented in Chicago is already making waves. Upon browsing ASCO abstracts, one of the world's top surgeons has just cold called me out of the blue, to buy the clinical Optellum software for their health system, and join the AI revolution in immunotherapy for early-stage NSCLC! Meet us at the ASCO science session and demos at the ConcertAI booth (see comments), at American Society of Clinical Oncology (ASCO)
